MAY 06, 2020 8:19 AM PDT

Breakthrough in Antibody Treatment for COVID-19

WRITTEN BY: Annie Lennon

Israeli scientists have announced significant progress in isolating an antibody that may be effective in treating those with coronavirus. Although not yet tested on animals nor humans, it shows signs of being able to neutralize the virus in humans. 

From research conducted by the Israel Institute of Biological Research, the antibody seems to meet three key parameters for treating the virus. Firstly, it is monoclonal. This means that it does not contain antibodies that would render it difficult to use. Next, tests have shown that the antibody is able to neutralize the virus. Lastly, the scientists showed that at least in a petri dish, the antibody is able to treat an aggressive strain of the virus. 

As far as we know, according to comprehensive scientific publication from around the world, the Biological Research Institute is the first in the world to achieve this breakthrough in these three parameters at the same time.” say the researchers. 

Although exact timelines are not yet known, the researchers will next test the antibody in animals, and then humans. Meanwhile, Professor Shumel Shapiro, the institute’s director said that the antibody is in the process of receiving a patent, and that the next phase of research includes contacting manufacturers around the world to put the antibody in mass production for commercial use. 

Given that close to 4 million people around the world have contracted the virus, with around 260,000 dead as of May 6 2020, many are optimistic on what this finding could mean for the future of the disease. 

Having called their finding a ‘significant breakthrough’, the researchers nevertheless warn that the treatment must still be confirmed in experimental settings and that a treatment made with the antibody will take time. 

“This is an important milestone, but afterwards comes complicated tests and a process of getting regulatory approval.” said the Biological Research Institute in a statement. “Per an assessment by the institute’s scientists, this technological breakthrough is poised to shorten the process, which will go on for several months.”


Sources: Forbes, Business Insider

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
JUL 21, 2020
Cardiology
Investigating New Anti-Blood Clotting Treatments
JUL 21, 2020
Investigating New Anti-Blood Clotting Treatments
When it comes to your cardiovascular health, it is important to look at more than just your heart. The cardiovascular sy ...
AUG 22, 2020
Drug Discovery & Development
Could a Drug for Bipolar Disorder Treat COVID-19?
AUG 22, 2020
Could a Drug for Bipolar Disorder Treat COVID-19?
Researchers have found that a drug currently used to treat bipolar disorder and hearing loss may also treat COVID-19 tha ...
AUG 17, 2020
Drug Discovery & Development
How Do Drugs Treat Parasitic Infections?
AUG 17, 2020
How Do Drugs Treat Parasitic Infections?
How Do Medications Deal With Parasitic Infections? Researchers have been curious to know how a common medication battles ...
AUG 25, 2020
Drug Discovery & Development
The Potential of Antivitamins
AUG 25, 2020
The Potential of Antivitamins
What exactly are antivitamins? They are substances no less that have the power to target the biological function of a ge ...
SEP 05, 2020
Drug Discovery & Development
Treatment in Cat Coronavirus Could Be Effective for Humans
SEP 05, 2020
Treatment in Cat Coronavirus Could Be Effective for Humans
Scientists at the University of Alberta are planning to launch clinical trials of a drug used to cure coronavirus in cat ...
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
Loading Comments...